Navigation Links
BioMedix™ Receives Patent for Its Innovative Collaborative Care Business Method

ST. PAUL, Minn., July 21, 2011 /PRNewswire/ -- BioMedix™, a leader in providing integrated Health Information Technology (HIT) products and services, has been awarded a U.S. Patent recognizing its innovative solutions and methods for detecting and managing cardiovascular disease.

On July 19, 2011, the United States Patent & Trademark Office issued U.S. Patent Number 7,983,930, entitled "System and Method for Testing for Cardiovascular Disease," crediting BioMedix™ President & CEO John Romans as inventor. The patent is now part of the growing portfolio of BioMedix™ intellectual property on innovative medical technologies, addressing testing, diagnosis and administrative processing across remote locations. The underlying concept, comprised of a collaborative care model utilizing the integrated suite of BioMedix™ solutions, facilitates partnership between primary care facilities and specialists, taking advantage of the specialists' expertise while still allowing testing to be easily performed at a variety of accessible test locations.

"This development allows specialists to have a virtual presence in every primary care setting, enabling improved care through cost-effective coordination and collaboration of physicians in different physical locations," stated John Romans.

The initial application of this invention has supported the improved detection, treatment and management of an under-diagnosed and costly vascular condition called Peripheral Artery Disease (P.A.D.). The BioMedix™ collaborative care network reduces time and travel for patient treatment while supporting improved patient outcomes. As part of this advanced web-based platform, BioMedix™ PADnet™ Disease Management System 2.0 provides a turnkey collaborative care solution for finding and managing patients with vascular disease utilizing the BioMedix™ PADnet™+, a non-invasive device for in-office testing. With a disease detection network made up of local hub-and-spoke networks across the country, BioMedix™ products and initiatives aim to address gaps in healthcare and disease detection.

Austen Zuege, shareholder at the intellectual property law firm Kinney & Lange, P.A. in Minneapolis said, "I am pleased to see the issuance of this patent, which demonstrates the high level of innovation at BioMedix™."

About BioMedix™

BioMedix™ is a leader in Health Information Technology (HIT) software, products and services that connect Podiatric Physicians, Primary Care Physicians, vascular labs, vascular specialists and healthcare systems in a continuum of collaborative care. We provide the only integrated suite of hardware, software and online services designed to cost-effectively detect vascular disease. Our award-winning suite of medical devices, advanced practice management and Electronic Health Record (EHR) software and web-based solutions give providers a more complete view of patient care. For more information about BioMedix™ products, call 877-854-0014 or log on to

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BioMedix™ Announces John Martin, MD, FACS, as Medical Director
2. BioMedix™ Now Exclusive Industry Distributor of the APMA Coding Resource Center
3. Agendia Receives €1.27 Million in Funding from the EUs Seventh Framework Programme
4. Cephalon Receives FDA Approval for Risk Evaluation and Mitigation Strategy for FENTORA and ACTIQ
5. Perrigo Receives FDA Approval to Market Coated Cinnamon Nicotine Gum
6. Luminex Corporation Receives U.S. FDA Clearance for New, Front Line Respiratory Viral Panel Test
7. UCLA Receives Six UC Health Quality Grants to Improve Hospital Care
8. Sequana Medical Receives CE Mark Approval for the ALFApump™ System and Adds Key Executive to Team
9. Chartwell Pharmaceuticals Receives Official FDA Registration
10. GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older
11. Sonitus Medical Receives Second FDA Clearance for SoundBite™ Hearing System
Post Your Comments:
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, a ... treatment outcomes for patients suffering from chronic pain, said ... a Temporary Restraining Order (TRO) enjoining Express Scripts from ... companies. --> --> ... of its legal options. --> ...
(Date:11/25/2015)... , Nov. 25, 2015 On ... first federal bellwether trial against Wright Medical Technology, ... to their Conserve metal-on-metal hip implant device, awarded ... Following a two week trial and three days ... metal-on-metal hip device was defectively designed and unreasonably ...
Breaking Medicine Technology:
(Date:11/26/2015)... BOSTON, Mass. (PRWEB) , ... November 26, 2015 ... ... a thorough second medical opinion process, participated in the 61st annual Employee Benefits ... Benefit Plans and took place Sunday, November 8th through Wednesday, November 11th, 2015. ...
(Date:11/25/2015)... ... 2015 , ... As part of a global movement to ... together who want to combine talents and resources to help create sustainable communities ... The non-profit launched its first major fundraiser on November 6, 2015 at Bent ...
(Date:11/25/2015)... NV (PRWEB) , ... November 25, 2015 , ... Dr. ... patients to learn more about hair loss treatment with the Capillus272™ Pro laser therapy ... effective solution for thicker and fuller hair, without the need for surgery, prescription pills, ...
(Date:11/25/2015)... ... 25, 2015 , ... Lakeview Health, a Jacksonville-based drug and ... sobriety and show through pictures what a positive difference it makes. The social ... the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram accounts. Short stories ...
(Date:11/25/2015)... ... , ... On November 23rd 2015 Cozy Products, a division of ... Cozy Products explains what this means for business moving forward. , The Tri Lite ... business model: to sell personal heaters that reduce energy consumption, are economical and keep ...
Breaking Medicine News(10 mins):